Treace Medical Q1 revenue falls 10% to $47.2M; net loss widens to $18.0M

TREACE MEDICAL CONCEPTS, INC.

2026-Q1 EPS reported -$0.28 revenue$47,198,000

Revenue $47.2M (-10% YoY); net loss $18.0M ($0.28 loss per share) vs $15.9M loss ($0.25) in Q1 2025.
Adjusted EBITDA loss of $5.5M vs $(3.8)M prior year; gross margin 79.3% nearly flat.
Cash, equivalents, and marketable securities $51.9M, up $3.5M from Dec 2025; $115M credit facility available.
FY2026 revenue guidance reaffirmed at $202-212M (decline 5% to 0%); adjusted EBITDA loss expected $4-6M.
CEO cites continued market share gains and case volume growth; initiated limited release of SuperBite Compression Screw System.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. reported the first quarter ended March 31, 2026 results: revenue $47.2 million, net income $(18.0) million, EPS $(0.28) per share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $47.2 million
Net income: $(18.0) million
EPS: $(0.28) per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026. Recent Highlights • Generated revenue of $47.2 million in first quarter 2026 compared to $52.6 million in the same period in 2025. • Reported first quarter 2026 net loss of $(18.0) million and adjusted EBITDA of $(5.5) million in the

View on SEC.gov

Browse all earnings releases →

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-213267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.